The JAK2 V617F mutation in de novo acute myelogenous leukemias

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

2005 • 3,482 citations

A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders

2005 • 3,402 citations

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

2005 • 3,358 citations

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

2005 • 2,958 citations

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

2001 • 2,749 citations

Polycythemia Vera: Stem-Cell and Probable Clonal Origin of the Disease

1976 • 655 citations

Chromosome Studies in 104 Patients With Polycythemia Vera

1991 • 152 citations

Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas

2002 • 145 citations

Jak family of kinases in cancer.

2003 • 141 citations

A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course

1988 • 133 citations

HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer

2002 • 82 citations

Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications

2003 • 32 citations